Atlas Trials

A Study to Assess the Effect of Itraconazole, Rifampin, and Acid-Reducing Agents on INCB161734 Pharmacokinetics When Administered Orally in Healthy Participants

Clinical trial NCT07018635 · COMPLETED

Trial details

NCT number
NCT07018635
Sponsor
Incyte Corporation
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Participants
Start date
2025-07-16
Primary completion
2025-09-29
Enrollment
63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.